Tag: inflammation
-

Immune Dysfunction and Progressive Heart Failure After Heart Attacks
Understanding the Link Between Immunity and Heart Failure When a heart attack damages heart muscle, the immediate concern is restoring blood flow and limiting further injury. But the aftermath involves a complex cascade of immune responses. Recent insights suggest that dysfunction within the immune system can propel the heart from injury toward progressive heart failure,…
-

Immune Dysfunction Drives Progressive Heart Failure After Heart Attacks
New Insights into the Aftermath of a Heart Attack When a heart attack damages the heart muscle, the body’s immediate response is to repair the tissue and restore blood flow. Yet for many survivors, the story doesn’t end there. Emerging research points to immune system dysfunction as a key driver of progressive heart failure, a…
-

Immune Dysfunction After Heart Attacks Drives Progressive HF
Understanding the Link Between Immune Dysfunction and Progressive Heart Failure When a heart attack damages the heart muscle, the body launches an immune response to clear damaged cells and begin repair. In many patients, this immune response is tightly regulated and resolves as healing progresses. In others, immune dysfunction persists, contributing to ongoing inflammation and…
-

How Lectins in the GI Tract Neutralize Bacteria to Protect Your Health
Understanding the GI Mucosal Barrier The lining of the gastrointestinal (GI) tract is more than a simple barrier. It is an active frontier of defense where mucosal surfaces host a dynamic immune system designed to distinguish between harmless microbes and potential threats. Central to this defense are specialized proteins known as lectins, which recognize specific…
-

Formosa Licenses Clobetasol Ophthalmic Suspension with Samil for Ocular Inflammation Treatment
Overview Formosa Pharmaceuticals, a Taiwan-based biopharma company, has announced an exclusive licensing agreement with Samil Pharmaceuticals Co., Ltd. for the commercialization of clobetasol propionate ophthalmic suspension. The collaboration aims to bring a potent topical corticosteroid therapy to patients suffering from ocular inflammation, expanding Formosa’s portfolio in ophthalmology and Samil’s international reach. About the Agreement The…





